Bipartisan support for cancer research has contributed to averting nearly four million deaths from cancer in the U.S. in the past three decades. Federal funding supports cutting-edge technologies, such as radiopharmaceuticals and artificial intelligence, that increase patients’ chance of survival and improve their quality of life, but sustained investment that grows with inflation is essential for continued progress in cancer treatment and prevention.
Radiation oncologists, therefore, are asking lawmakers to increase funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI). In addition, they are encouraging lawmakers to adequately fund the new Advanced Research Projects Agency for Health (ARPA-H) without pulling funding from other NIH programs, and to ensure that the Cancer Moonshot 2.0 initiative includes efforts to improve radiation therapy access, address health disparities and reduce obstacles to care such as treatment delays.
Ad Statistics
Times Displayed: 1943
Times Visited: 9 Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.
ABOUT ASTRO
The American Society for Radiation Oncology (ASTRO) is the largest radiation oncology society in the world, with nearly 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other professionals who specialize in treating patients with radiation therapies.
Back to HCB News
